Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan

Go back to Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan
Bristol-Myers Squibb (NYSE: BMY) Delayed: 63.06 +0.22 (0.35%)
Previous Close $62.84    52 Week High $77.12 
Open $62.71    52 Week Low $49.03 
Day High $63.07    P/E 40.95 
Day Low $62.19    EPS $1.54 
Volume 36,848,550       

Pfizer Inc. (NYSE: PFE) Delayed: 27.66 +0.02 (0.07%)
Previous Close $27.64    52 Week High $37.39 
Open $27.64    52 Week Low $28.25 
Day High $27.66    P/E 16.76 
Day Low $27.34    EPS $1.65 
Volume 75,587,710       

PORTOLA PHARMAC (NASDAQ: PTLA) Delayed: 18.03 --0 (-0%)
Previous Close $18.03    52 Week High $52.89 
Open $0.13    52 Week Low $15.68 
Day High $18.03    P/E 41.93 
Day Low $18.03    EPS $0.43 
Volume 15